Powder: -20°C for 3 years | In solvent: -80°C for 1 year
CHIR 98024 is a potent GSK-3α/β inhibitor with IC50 of 0.65 nM/0.58 nM in cell-free assays, with the ability to distinguish GSK-3 from its closest homologs Cdc2 and ERK2.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 37.00 | |
2 mg | In stock | $ 50.00 | |
5 mg | In stock | $ 97.00 | |
10 mg | In stock | $ 155.00 | |
25 mg | In stock | $ 313.00 | |
50 mg | In stock | $ 513.00 | |
100 mg | In stock | $ 743.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 98.00 |
Description | CHIR 98024 is a potent GSK-3α/β inhibitor with IC50 of 0.65 nM/0.58 nM in cell-free assays, with the ability to distinguish GSK-3 from its closest homologs Cdc2 and ERK2. |
Targets&IC50 | GSK-3α:0.65 nM, GSK-3β:0.58 nM |
Synonyms | CHIR98014 |
Molecular Weight | 486.31 |
Formula | C20H17Cl2N9O2 |
CAS No. | 556813-39-9 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
H2O: < 1 mg/mL (insoluble or slightly soluble)
DMSO: 8 mg/mL
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
CHIR 98024 556813-39-9 MAPK PI3K/Akt/mTOR signaling Stem Cells GSK-3 S6 Kinase inhibit ischemic stroke CHIR98024 Glycogen synthase kinase 3 CHIR-98024 Inhibitor CHIR 98014 Glycogen synthase kinase-3 CHIR98014 CHIR-98014 inhibitor